Nevropram (Citalopram Hydrobromide)

Citalopram hydrobromide, the active ingredient in Nevropram, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral use. It is indicated for the treatment of major depressive disorder and related anxiety conditions in adult patients.

GNH USA supplies Nevropram as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Nevropram (citalopram hydrobromide) acts on the serotonergic pathway and is prescribed for several mood and anxiety disorders. - Major depressive disorder: reduces depressive symptoms and improves mood. - Obsessive‑compulsive disorder: lessens intrusive thoughts and compulsive behaviors. - Panic disorder: decreases frequency and intensity of panic attacks. - Social anxiety disorder: alleviates fear of social situations and improves functioning.

Citalopram may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Nausea: mild gastrointestinal upset. - Headache: transient cranial discomfort. - Sexual dysfunction: decreased libido or delayed orgasm. Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Suicidal thoughts: emergence of suicidal ideation, especially early in treatment. - QT interval prolongation: cardiac rhythm disturbances.

Before initiating therapy, clinicians should consider several safety measures. - Psychiatric assessment: evaluate baseline mood and suicidal risk before starting treatment. - Concomitant MAOI use: avoid co‑administration and maintain a minimum 14‑day washout period. - Hepatic impairment: adjust dose or monitor closely in patients with liver dysfunction. - Elderly patients: start at lower dose and monitor for hyponatremia. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Citalopram can interact with several drug classes, requiring careful management. Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome; must not be combined. - Pimozide: can cause serious cardiac effects when used together. - Other serotonergic agents (e.g., tramadol, linezolid): increase risk of serotonin syndrome. Moderate Interactions (Monitor Closely): - NSAIDs or anticoagulants: may elevate bleeding risk. - CYP2C19 inhibitors (e.g., fluoxetine, omeprazole): can raise citalopram plasma levels. - Alcohol: may enhance central nervous system depression. - Antihistamines with anticholinergic properties: may worsen dry mouth.